Briefing: Pfizer’s Lyme Vaccine Results Set Up Tricky Regulatory Path
Strategic angle: New results on Pfizer's Lyme disease vaccine raise questions about its regulatory approval.
Editorial Staff
1 min read
Updated 4 months ago
Pfizer's Lyme vaccine shows promising results.
Regulatory challenges may complicate approval process.
Potential impact on drug supply chains due to geopolitical tensions.